NCT00610038View on ClinicalTrials.gov

Efficacy and Safety Study of Sulfonylureas in Neonatal Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

August 31, 2010

Study Completion Date

December 31, 2011

Conditions
Diabetes Mellitus
Interventions
DRUG

glibenclamide

Switching the patients from subcutaneous insulin to oral glibenclamide therapy

Trial Locations (1)

75015

Necker Hospital - Endocrinology Gynecology Pediatric unit, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT00610038 - Efficacy and Safety Study of Sulfonylureas in Neonatal Diabetes Mellitus | Biotech Hunter | Biotech Hunter